1 Exclusion criteria were age <18 years, ABO incompatibility, r
2 Exclusion criteria were age less than 18 years, no light perc
3 Exclusion criteria were an active infection or fistula, antib
4 1029 eyes from 1029 participants who met the inclusion and
exclusion criteria were analyzed, including only 1 eye per pa
5 Exclusion criteria were any ophthalmic surgical procedures wi
6 No
exclusion criteria were applied after including all invasive
7 Inclusion and
exclusion criteria were applied by 2 independent coders with
8 After inclusion and
exclusion criteria were applied, the study population include
9 e recalled (recall rate, 4.8%), and 827 were included after
exclusion criteria were applied.
10 admissions (10%) were eligible for analysis once predefined
exclusion criteria were applied: 4,804 (31.7%) received "noni
11 Exclusion criteria were as follows: (1) the purpose of the di
12 Exclusion criteria were as follows: age less than 16 years ol
13 Exclusion criteria were being nulliparous, having missing par
14 Exclusion criteria were being too physically unwell to attend
15 Exclusion criteria were Body-Mass index (BMI) > 40, liver met
16 Exclusion criteria were conditions with increased risk for CR
17 Exclusion criteria were contrast material-enhanced chest CT p
18 Exclusion criteria were date of diagnosis before 2007 or afte
19 Exclusion criteria were diabetes mellitus, history of stroke,
20 Exclusion criteria were disorders of consciousness lasting mo
21 Inclusion and
exclusion criteria were employed as follows; (1) study publis
22 Given the rarity of patient-matched samples, no
exclusion criteria were enacted.
23 Exclusion criteria were gestational age <32 weeks, birth weig
24 Exclusion criteria were:
history of dementia, cardiac or intr
25 A total of 274 patients meeting inclusion and
exclusion criteria were identified and 132 patients were incl
26 Exclusion criteria were in vitro resistance to FT or concomit
27 Exclusion criteria were intraocular involvement, orbital lymp
28 Exclusion criteria were intravitreal antibiotic injection and
29 were met by 71 633 (71.8%) patients, and both inclusion and
exclusion criteria were met by 20 704 (20.8%) patients.
30 Exclusion criteria were missing data for either race or initi
31 Exclusion criteria were missing key data, death sooner than 2
32 Exclusion criteria were neoadjuvant therapy and incomplete fo
33 Exclusion criteria were neoadjuvant therapy, vascular- and un
34 Exclusion criteria were neoadjuvant treatment or pancreatitis
35 Exclusion criteria were newly implanted leads, abandoned or e
36 Exclusion criteria were non-DR retinal disease and inability
37 s AKI stages 1 to 3 (Acute Kidney Injury Network criteria),
exclusion criteria were obstructive uropathy, urothelial carc
38 Exclusion criteria were patients having a previous known LVEF
39 The
exclusion criteria were patients who (1) first presented with
40 Exclusion criteria were patients with missing or noncontribut
41 The
exclusion criteria were presenting more than 14 days after in
42 Exclusion criteria were prior intravitreal anti-VEGF treatmen
43 Exclusion criteria were prior radiation treatment on vertebra
44 Exclusion criteria were severe systemic disease, pregnancy, c
45 Exclusion criteria were severe systemic disease, pregnancy, c
46 30, 2017, 1,262 consecutive patients who met inclusion and
exclusion criteria were studied.
47 Exclusion criteria were studies of inflammatory bowel disease
48 Main
exclusion criteria were:
symptoms for longer than 3 weeks, th
49 Exclusion criteria were temporary residence, inability to tak
50 Inclusion and organ-specific
exclusion criteria were the most common reason for not procee